ALPHARETTA, Ga.--(BUSINESS WIRE)-- CSI Laboratories announced that Ms. Heather Creran has been appointed President and Chief Executive Officer, overseeing all commercial and strategic operations for the company.
Ms. Creran has held the role of President and Chief Operating Officer of CSI Laboratories for the past three years and has served in executive leadership positions with several national laboratories prior to joining CSI. Ms. Creran spent 14 years with IMPATH, Inc., including five years as Vice President of Operations. Following her time with IMPATH, she was appointed Executive Vice President and Chief Operating Officer of Clarient, Inc., and was instrumental in transforming the company from an instrumentation manufacturer into a national anatomic pathology laboratory.
Ron Ghafary, Chairman and Founder, stated, “We are very fortunate to have Heather at the helm. For the past three years, her operational expertise led us in expanding our services. Under her management, CSI Laboratories has become a recognized leader in oncology testing. We look forward to continuing our strong growth and profitability with her as our Chief Executive Officer.”
About CSI Laboratories
CSI Laboratories is a specialized cancer diagnostic laboratory focused specifically on meeting the unique needs and challenges of pathologists and community hospitals. The company provides diagnostic testing in flow cytometry, cytogenetic analysis, fluorescence in-situ hybridization (FISH), immunohistochemistry, molecular genetics and consultations in the areas of hematopathology and surgical pathology. All of CSI’s testing services are performed in its CLIA-certified and CAP-accredited laboratory located in Alpharetta, GA. CSI Laboratories is independently owned and operated by medical professionals and has provided expert diagnostic testing to physicians across the United States since 1997.
KEYWORDS: United States North America Georgia
INDUSTRY KEYWORDS: Health Oncology Managed Care